Luyan Pharma Co.,Ltd. (SHE:002788)
China flag China · Delayed Price · Currency is CNY
13.76
-0.40 (-2.82%)
Apr 29, 2026, 3:04 PM CST

Luyan Pharma Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21 2020 - 2016
Cash & Equivalents
--576.85606.3594.19415.43
Upgrade
Cash & Short-Term Investments
--576.85606.3594.19415.43
Upgrade
Cash Growth
---4.86%2.04%43.03%-30.40%
Upgrade
Accounts Receivable
--5,9515,6735,8495,101
Upgrade
Other Receivables
--108.3394.5987.49117.17
Upgrade
Receivables
--6,0595,7685,9375,218
Upgrade
Inventory
--2,8652,5742,5492,275
Upgrade
Prepaid Expenses
--0.020.250.330.08
Upgrade
Other Current Assets
--369.1370.33668.17414.12
Upgrade
Total Current Assets
--9,8709,3199,7488,322
Upgrade
Property, Plant & Equipment
--1,9281,6531,4251,037
Upgrade
Long-Term Investments
--53.4148.8534.2131.3
Upgrade
Goodwill
--289.28288.65289.45289.45
Upgrade
Other Intangible Assets
--361.09355.16176.93167.81
Upgrade
Long-Term Deferred Tax Assets
--75.7966.3754.7143.39
Upgrade
Long-Term Deferred Charges
--29.0428.5828.9632.82
Upgrade
Other Long-Term Assets
--31.534.4626.0868.98
Upgrade
Total Assets
--12,63911,79411,7849,993
Upgrade
Accounts Payable
--4,0043,4443,2582,410
Upgrade
Accrued Expenses
--86.7498.53119.54111.6
Upgrade
Short-Term Debt
--3,8753,9904,4554,130
Upgrade
Current Portion of Long-Term Debt
--293.91171.2658.2547.31
Upgrade
Current Portion of Leases
--46.6743.5437.9841.69
Upgrade
Current Income Taxes Payable
--36.6743.9843.4745.42
Upgrade
Current Unearned Revenue
--30.7222.3831.7810.57
Upgrade
Other Current Liabilities
--232.47211.84296.53217.69
Upgrade
Total Current Liabilities
--8,6058,0268,3017,015
Upgrade
Long-Term Debt
--648.41578.63475.04226.6
Upgrade
Long-Term Leases
--87.3374.3353.8640.37
Upgrade
Long-Term Unearned Revenue
--38.8339.7641.241.85
Upgrade
Long-Term Deferred Tax Liabilities
--6.546.817.077.34
Upgrade
Other Long-Term Liabilities
--60.1490.98114.97101.17
Upgrade
Total Liabilities
--9,4478,8178,9937,433
Upgrade
Common Stock
--388.52388.52388.52388.52
Upgrade
Additional Paid-In Capital
--617.54631.05653.6656.37
Upgrade
Retained Earnings
--2,1521,9231,6761,447
Upgrade
Comprehensive Income & Other
--4.243.842.82-0.5
Upgrade
Total Common Equity
--3,1622,9462,7212,492
Upgrade
Minority Interest
--29.6730.6869.8468.47
Upgrade
Shareholders' Equity
--3,1922,9772,7912,560
Upgrade
Total Liabilities & Equity
--12,63911,79411,7849,993
Upgrade
Total Debt
--4,9514,8585,0804,486
Upgrade
Net Cash (Debt)
---4,374-4,252-4,486-4,071
Upgrade
Net Cash Per Share
---11.26-10.99-11.57-10.51
Upgrade
Filing Date Shares Outstanding
399.63404.33388.52388.52388.52388.52
Upgrade
Total Common Shares Outstanding
399.63404.33388.52388.52388.52388.52
Upgrade
Working Capital
--1,2651,2921,4471,307
Upgrade
Book Value Per Share
--8.147.587.006.41
Upgrade
Tangible Book Value
--2,5122,3022,2542,034
Upgrade
Tangible Book Value Per Share
--6.475.935.805.24
Upgrade
Buildings
--1,4431,001899.38858.76
Upgrade
Machinery
--278.43259.22214.51196.8
Upgrade
Construction In Progress
--471.48616.59509.06139.74
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.